专利检索 ap:("Aventis Pharma S.A." OR "INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)") AND inv:"ARNOULD-REGUIGNE, Isabelle" 第 2 页

11.

发明公开
COMPOSITIONS UTILISABLES POUR REGULER L'ACTIVITE DE LA PARKINE 有权
标题翻译：用于控制PARK不活跃的组合物

公开(公告)号：EP1259606A2

公开(公告)日：2002-11-27

申请号：EP01907820.3

申请日：2001-02-15

申请人： Aventis Pharma S.A. , INSTITUT NATIONAL DE LA SANTE ET DE LARECHERCHE MEDICALE (INSERM)

发明人： KOUTNIKOVA, Hana , BRICE, Alexis , FOURNIER, Alain , PRADIER, Laurent , PRADES, Catherine , ARNOULD-REGUIGNE, Isabelle , ROSIER-MONTUS, Marie-Françoise , CORTI, Olga

IPC分类号： C12N15/12 , C12N5/10 , C07K14/47 , C07K16/18 , G01N33/50 , A61K38/17

CPC分类号： C07K14/47 , A01K2217/05 , A61K38/00 , A61K48/00 , C07K2319/00

摘要： The invention concerns novel compounds and their uses, in particular pharmaceutical, diagnostic or as pharmacological targets. More particularly, the invention concerns a novel protein, called PAP1, and novel peptides and compounds capable of modulating at least partially parkin gene activity.